Chemical Structure : Lucerastat
CAS No.: 141206-42-0
Catalog No.: PC-61429Not For Human Use, Lab Use Only.
Lucerastat (NB-DGJ, ACT-434964) is a galactose analogue that is an UDP-glucose ceramide glucosyltransferase (UGCG/GCS) inhibitor (IC50=41.4 uM).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $148 | In stock | |
10 mg | $218 | In stock | |
25 mg | $378 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Lucerastat (NB-DGJ, ACT-434964) is a galactose analogue that is an UDP-glucose ceramide glucosyltransferase (UGCG/GCS) inhibitor (IC50=41.4 uM).
Lucerastat prevents glucosylceramide biosynthesis both in vitro and in mouse models of lysosome storage disorders, without affecting α-glucosidase I and II or β-glucocerebrosidase (IC50>1 mM).
Lucerastat shows potential as substrate reduction therapy for glycolipid storage disorders such as Gaucher disease and Fabry disease.
M.Wt | 219.281 | |
Formula | C10H21NO4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol |
1. Platt FM, et al. J Biol Chem. 1994 Oct 28;269(43):27108-14.
2. Andersson U, et al. Biochem Pharmacol. 2000 Apr 1;59(7):821-9.
3. Kasperzyk JL, et al. J Neurochem. 2004 May;89(3):645-53.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright